NEXVOUND Trademark

Trademark Overview


On Friday, November 21, 2025, a trademark application was filed for NEXVOUND with the United States Patent and Trademark Office. The USPTO has given the NEXVOUND trademark a serial number of 99509700. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 6, 2026. This trademark is owned by Eli Lilly and Company. The NEXVOUND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial ...
nexvound

General Information


Serial Number99509700
Word MarkNEXVOUND
Filing DateFriday, November 21, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the literal element "NEXVOUND" with the "N" capitalized and the remaining in lowercase with a graphic representation of a broken circular shape encompassing "VOU" in the color blue.
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 21, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Friday, November 21, 2025NEW APPLICATION ENTERED
Friday, November 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, December 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 17, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 22, 2025ASSIGNED TO EXAMINER
Tuesday, January 6, 2026NON-FINAL ACTION WRITTEN
Tuesday, January 6, 2026NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED